Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation.
Fieguth
Hans-Gerd
HG
Division of Thoracic and Cardiovascular Surgery, University Hospital, D-60 590 Frankfurt, Germany.
Krueger
S
S
Wiedenmann
D E
DE
Otterbach
I
I
Wagner
T O F
TO
D000328:Adult; D001989:Bronchiolitis Obliterans / Q000601:surgery*; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005541:Forced Expiratory Volume; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016040:Lung Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D029424:Pulmonary Disease, Chronic Obstructive / Q000601:surgery; D011658:Pulmonary Fibrosis / Q000601:surgery; D012086:Reoperation; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D016559:Tacrolimus